UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 21, 2015

 

 

IMS Health Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36381   27-1335689

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

83 Wooster Heights Road

Danbury, CT 06810

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (203) 448-4600

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders

The Company’s 2015 Annual Meeting of Shareholders was held on April 21, 2015. At the meeting, shareholders voted on the following items:

Proposal 1: The following nominees were elected by majority vote to serve on the Board of Directors:

 

     For      Against      Abstain      Broker Non-Vote  

Ari Bousbib

     300,578,109         9,329,192         33,402         1,655,646   

James A. Fasano

     283,775,683         26,157,870         7,150         1,655,646   

Todd B. Sisitsky

     277,502,961         32,430,592         7,150         1,655,646   

Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal 2015 was ratified.

 

For

 

Against

 

Abstain

 

Broker Non-Vote

310,543,728

  1,046,777   5,844   N/A

Proposal 3: An advisory vote on executive compensation was approved.

 

For

 

Against

 

Abstain

 

Broker Non-Vote

284,140,549

  25,788,752   11,402   1,655,646

Proposal No. 4: An advisory vote on the frequency of advisory votes on the compensation of the Company’s named executive officers every three years was approved.

 

One Year

 

Two Years

 

Three Years

 

Abstain

 

Broker Non-Vote

39,452,927

  4,231   270,500,135   10,656   1,628,400


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

IMS Health Holdings, Inc.
Date: April 27, 2015 By:

/s/ Ronald E. Bruehlman

Name: Ronald E. Bruehlman
Title:

Senior Vice President and

Chief Financial Officer